SOC 2 vs. HIPAA: Choosing the Right Path for HealthTech

Every HealthTech founder eventually gets the same two requests in the same quarter. A hospital system’s procurement team asks for a SOC 2 report. A payer’s legal team asks for HIPAA evidence and a signed business associate agreement. Both feel urgent, both feel expensive, and the natural instinct is to pick one and get through it.

The better move is to understand how they differ, where they overlap, and then sequence them so that the second one costs a fraction of the first.

They are different kinds of things

HIPAA is law. If you create, receive, maintain, or transmit protected health information on behalf of a covered entity, you are a business associate and the HIPAA Security Rule (45 CFR Part 164, Subpart C) applies to you whether or not anyone asks. There is no certificate. There is no auditor who stamps you “HIPAA compliant.” There is a set of required and addressable safeguards, a mandatory risk analysis, and an enforcement agency (HHS Office for Civil Rights) that investigates after a breach or complaint.

SOC 2 is an attestation. It is a report issued by a licensed CPA firm, under the AICPA’s attestation standards, on whether your controls meet the Trust Services Criteria you chose to include. Nobody is legally required to have one. Customers ask for it because it is the most widely accepted way to prove that an independent party examined your controls. A Type I report describes controls at a point in time; a Type II report tests them over a period, usually six to twelve months.

The distinction matters for how you approach each one. HIPAA is about meeting a legal obligation and being able to prove it if investigated. SOC 2 is about satisfying a customer’s procurement process. Conflating them leads to teams that have a report but not a program, or a program with nothing to show a buyer.

Where they overlap

The good news is that the substance overlaps heavily. Both expect you to:

• Perform and document a risk assessment
• Control who can access systems and data, and review that access
• Encrypt data in transit and at rest
• Log and monitor activity, and retain the logs
• Have an incident response plan, and test it
• Manage vendors who touch your data
• Train your workforce and document it
• Back up data and be able to restore it

Build those controls once, with evidence, and you have covered most of both. What differs is the packaging: HIPAA wants a risk analysis and policies mapped to its specific safeguards; SOC 2 wants control descriptions and evidence samples mapped to the Trust Services Criteria. The controls are the same. The paperwork is different.

Which one first

For most HealthTech companies, HIPAA first, for three reasons.

First, it is the legal obligation. If you handle PHI, you are already subject to it, and the risk analysis it requires is the foundation for everything else, including SOC 2’s own risk assessment criteria.

Second, the customers who care about HIPAA (providers, payers, anyone regulated) usually will not sign a contract without a BAA and some evidence of a program. SOC 2 helps in that conversation, but it does not substitute for HIPAA evidence.

Third, doing HIPAA properly produces most of the SOC 2 evidence as a by-product. Policies, risk register, access reviews, training records, incident plan: all of it carries over. Going the other direction works too, but teams that start with SOC 2 often scope it narrowly around a product and leave the corporate environment out, which is exactly where HIPAA will find gaps.

The exception is a company that does not yet handle PHI, or handles only de-identified data, and is selling into enterprises that require SOC 2 regardless. Then SOC 2 leads, with the HIPAA-specific pieces added when the first PHI contract arrives.

Practical sequencing

A realistic path for a Series A HealthTech company looks like this:

1. Scope. Decide what systems handle PHI and what the SOC 2 boundary will be. Make them the same boundary where possible. Narrow scope saves money on the audit and creates gaps in the program; pick the trade-off on purpose.
2. HIPAA risk analysis and policy set. This produces the control list you will implement.
3. Implement and collect evidence. Identity and access, logging, encryption, vendor reviews, training. Use a compliance automation platform if it fits your stack; it reduces evidence collection but does not replace the decisions.
4. SOC 2 readiness review. A gap assessment against the Trust Services Criteria, using the evidence you already have.
5. Type I, then Type II. The Type I gets you a report to hand to procurement quickly; the Type II observation period starts the same day.

Companies that follow this order typically find that the SOC 2 work is mostly documentation and evidence formatting rather than new controls. Companies that go the other way often end up doing two programs.

What to avoid

• Buying “HIPAA compliant” as a label. Vendors will tell you their product is HIPAA compliant. Products are not; organizations are. A HIPAA-eligible cloud service still requires you to configure and operate it correctly, and to sign a BAA with the provider.
• Scoping SOC 2 so narrowly that it excludes your real environment. Sophisticated buyers read the scope section. A report that covers one application and excludes corporate IT raises more questions than it answers.
• Treating either one as finished. HIPAA requires periodic risk analysis. SOC 2 Type II is an annual cycle. Both are programs, not projects.

How we help

Our Compliance Assessments work starts with scoping so you build once and map twice. If you are trying to decide which comes first for your company, the framework finder gives you a starting point in five questions, and a scoping call settles it in an hour.

This article is general guidance, not legal advice. HIPAA obligations depend on your specific role and contracts; confirm them with counsel.